CAR T-cell therapy, a revolutionary technology originally developed for blood cancers, may also help in restoring the immune system in severe autoimm1
The Clínic Barcelona Comprehensive Cancer Center (4CB), driven by Hospital Clínic Barcelona, IDIBAPS, and the University of Barcelona, has announced1
This comprehensive preparation, which combines supervised physical exercise, nutritional advice and psychological support, has been associated with a1
Last Tuesday, 15 October 2024, IDIBAPS received a visit from thirty people, most of them patients with liver cancer under treatment at the Hospital C1
The Joan Rodés-Josep Baselga Advanced Research Contracts in Oncology and Neurodegenerative Diseases, awarded by the BBVA Foundation and Hospital Clín1
Interview with Dr. M. José Ribal, Head of the Urological Onocology Unit. Dra. Ribal has been appointed the new presiden1
The IDIBAPS governing board has approved the creation of a new research group. The decision is in response to the results of scientific evaluation, c1
Dr. Aleix Prat, head of the Service of Medical Oncology at Hospital Clínic, head of the Translational genomics and targeted therapies in solid tumour1
Hospital Clínic of Barcelona will apply the leading comprehensive liquid biopsy test currently available for patients with advanced cancer, in the co1
